Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03769493 · ClinicalTrials.gov registry record · NA

Mobile After-Care Intervention to Support Post-Hospital Transition (MACS)

A NA study of Psychotic Disorders, sponsored by Butler Hospital.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT03769493 is a NA study of Psychotic Disorders that has completed, run by Butler Hospital. The registered enrollment target is 10 participants, below the 255-participant average among 22 other Psychotic Disorders trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03769493, a NA study of Psychotic Disorders, has completed, sponsored by Butler Hospital.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This study examines the feasibility and acceptability of a mobile device-delivered app, called Mobile After-Care Support (MACS), to improve patients' coping and treatment adherence following a hospitalization related to their psychotic-spectrum disorder.

Conditions Studied

Interventions

  • BEHAVIORAL Mobile After-Care Support (MACS) app

Study Locations (1)

Rhode Island

  • Butler Hospital - Providence

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-01-16
Est. Completion 2019-10-15
Phase NA

Sponsor

Butler Hospital

103 total trials

What the Registry Record Tells You About NCT03769493

The ClinicalTrials.gov registry entry for NCT03769493 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 255-participant average among 22 other Psychotic Disorders trials with a reported enrollment target (96% lower). The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Psychotic Disorders appearing as the primary indexed condition, and to 1 intervention - of which Mobile After-Care Support (MACS) app is the first listed.

NCT03769493 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT03769493 about?

NCT03769493 is a clinical study titled "Mobile After-Care Intervention to Support Post-Hospital Transition (MACS)". This study examines the feasibility and acceptability of a mobile device-delivered app, called Mobile After-Care Support (MACS), to improve patients' coping and treatment adherence following a hospitalization related to their psychotic-spectrum disorder.

What is the current status of trial NCT03769493?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-01-16. Estimated completion is 2019-10-15.

What conditions does trial NCT03769493 study?

This clinical trial studies the following conditions: Psychotic Disorders.

What interventions are being tested in trial NCT03769493?

The interventions under investigation include: Mobile After-Care Support (MACS) app (BEHAVIORAL).

Who is sponsoring clinical trial NCT03769493?

This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03769493 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psychotic Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.